Sangamo BioSciences (SGMO) PT Lowered to $9 at Stifel, Following Clinical Business Update
Tweet Send to a Friend
Stifel analyst Benjamin J. Burnett lowered the price target on Sangamo BioSciences (NASDAQ: SGMO) to $9.00 (from $12.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
